Recro Gainesville Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RECRO GAINESVILLE, and when can generic versions of RECRO GAINESVILLE drugs launch?
RECRO GAINESVILLE has one approved drug.
There are sixteen US patents protecting RECRO GAINESVILLE drugs.
There are thirty patent family members on RECRO GAINESVILLE drugs in twenty-three countries.
Summary for Recro Gainesville
International Patents: | 30 |
US Patents: | 16 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Recro Gainesville: | See patent lawsuits for Recro Gainesville |
Drugs and US Patents for Recro Gainesville
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-005 | Oct 25, 2013 | DISCN | Yes | No | 9,433,619 | ⤷ Sign Up | ⤷ Sign Up | ||||
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-001 | Oct 25, 2013 | DISCN | Yes | No | 9,333,201 | ⤷ Sign Up | ⤷ Sign Up | ||||
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-001 | Oct 25, 2013 | DISCN | Yes | No | 10,322,120 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-003 | Oct 25, 2013 | DISCN | Yes | No | 9,326,982 | ⤷ Sign Up | ⤷ Sign Up | ||||
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-003 | Oct 25, 2013 | DISCN | Yes | No | 9,610,286 | ⤷ Sign Up | ⤷ Sign Up | ||||
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-002 | Oct 25, 2013 | DISCN | Yes | No | 10,028,946 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Recro Gainesville
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-006 | Oct 25, 2013 | 6,228,398 | ⤷ Sign Up |
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-004 | Oct 25, 2013 | 6,902,742 | ⤷ Sign Up |
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-001 | Oct 25, 2013 | 6,228,398 | ⤷ Sign Up |
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-002 | Oct 25, 2013 | 6,228,398 | ⤷ Sign Up |
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-005 | Oct 25, 2013 | 6,902,742 | ⤷ Sign Up |
Recro Gainesville | ZOHYDRO ER | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 202880-002 | Oct 25, 2013 | 6,902,742 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RECRO GAINESVILLE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Capsules | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg | ➤ Subscribe | 2014-02-26 |
International Patents for Recro Gainesville Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112017004882 | ⤷ Sign Up |
Japan | 6929407 | ⤷ Sign Up |
Poland | 3191085 | ⤷ Sign Up |
Denmark | 3191085 | ⤷ Sign Up |
Russian Federation | 2017112301 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2014022570 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.